Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENTING PNEUMO 2
ISRCTN15728847Phase 4Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised, double-blind trial of pneumococcal 13-valent conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine and sodium chloride in pneumococcal disease and pneumonia, sponsored by Liverpool School of Tropical Medicine. Started Jul 2021; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccinesodium chloride
03
Conditions
pneumococcal diseasepneumonia
Beyond the preview
Go deeper on ISRCTN15728847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15728847.